SCHEMBL2599658

SCHEMBL2599658

CCCC[C@H](CC)CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9004577 1.00 ALDH1A1 (1.00)
SCHEMBL28690 1.00
SCHEMBL13478297 1.00
SCHEMBL7205000 0.97
Bromide SCHEMBL3913876 0.97 ALDH1A1 (0.95)
SCHEMBL1931933 0.97 ALDH1A1 (0.95)
Water SCHEMBL1584914 0.97 ALDH1A1 (0.95)
SCHEMBL6935237 0.97 ALDH1A1 (0.95)
Methylamine SCHEMBL6868280 0.97 ALDH1A1 (0.95)
Hydrochloric Acid SCHEMBL2772983 0.97 ALDH1A1 (0.95)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025093724-A1 INSULATING EDGE COATING NORTHVOLT AB (SE) 2025-05-08 WO disclosed
WO-2025012257-A1 BINDER FOR A SECONDARY CELL NORTHVOLT AB (SE) 2025-01-16 WO disclosed
WO-2023283434-A9 AMINOOXY CLICK CHEMISTRY (AOCC): A VERSATILE BIOCONJUGATION APPROACH ALNYLAM PHARMACEUTICALS, INC. (US) 2024-03-28 WO disclosed
EP-3724248-A1 POLYMERS WITH ENGINEERED SEGMENT MOLECULAR WEIGHTS A&AT LLC (US) 2020-10-21 EP disclosed
WO-2019118604-A1 POLYMERS WITH ENGINEERED SEGMENT MOLECULAR WEIGHTS A&AT LLC (US) 2019-06-20 WO disclosed
WO-2018119440-A1 COMPOSITIONS AND METHODS FOR INHIBITING ARGINASE ACTIVITY CALITHERA BIOSCIENCES, INC. (US) 2018-06-28 WO disclosed
WO-2011144530-A1 PROCESS FOR JOINING TOGETHER COMPONENTS, IN PARTICULAR IN THE PRODUCTION OF SHOES BAYER MATERIALSCIENCE AG (DE) 2011-11-24 WO disclosed
EP-1586319-B1 Thiadiazolidinones as GSK-3 inhibitors NOSCIRA SA (ES) 2009-10-21 EP disclosed
WO-2008106226-A2 MACROLIDE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME RIB-X PHARMACEUTICALS, INC. (US) 2008-09-04 WO disclosed